Research Article
Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal
Table 2
Univariable and multivariable Cox analysis of prognostic factors for overall survival in 503 patients with esophageal squamous cell carcinoma.
| | Univariable analysis | Multivariable analysis | HR (95% CI) | value | HR (95% CI) | value |
| Age, year | 1.01 (0.99-1.03) | 0.11 | | | Sex | | | | | Male | Ref | | | | Female | 0.74 (0.54-1.02) | 0.07 | | | BMI, kg/m2 | 0.97 (0.93-1.01) | 0.12 | | | Tobacco use | | | | | No | Ref | | | | Yes | 1.11 (0.86-1.42) | 0.42 | | | Alcohol use | | | | | No | Ref | | | | Yes | 1.14 (0.87-1.49) | 0.35 | | | Comorbidities history of hypertension | | | | | No | Ref | | | | Yes | 1.10 (0.85-1.41) | 0.48 | | | History of diabetes | | | | | No | Ref | | | | Yes | 1.18 (0.90-1.56) | 0.23 | | | History of COPD | | | | | No | Ref | | Ref | | Yes | 1.50 (1.08-2.10) | 0.02 | 1.79 (1.27-2.53) | <0.001 | History of hepatitis | | | | | No | Ref | | | | Yes | 1.03 (0.74-1.44) | 0.84 | | | History of cardiovascular disease | | | | | No | Ref | | | | Yes | 0.92 (0.66-1.29) | 0.62 | | | Preoperative albumin, g/L | 0.96 (0.93-0.99) | 0.03 | | | Preoperative platelet, | 1 (0.998-1.002) | 0.63 | | | Preoperative WBC, 109 | 1.06 (1.004-1.129) | 0.04 | | | Preoperative NLR | 1.06 (1.006-1.117) | 0.03 | | | Length of tumor, cm | 1.18 (1.11-1.25) | <0.001 | | | Location of tumor | | | | | Upper | Ref | | | | Middle | 0.86 (0.62-1.19) | 0.35 | | | Lower | 0.91 (0.62-1.33) | 0.62 | | | Differentiation of tumor | | | | | Well | Ref | | | | Moderate | 1.69 (1.09-2.62) | 0.02 | | | Poor | 2.19 (1.37-3.49) | <0.001 | | | Pathological T stage | | | | | T1 | Ref | | Ref | | T2 | 2.51 (1.43-4.41) | 0.001 | 1.82 (1.02-3.22) | 0.004 | T3 | 4.76 (2.80-8.10) | <0.001 | 3.01 (1.74-5.20) | <0.001 | T4 | 6.33 (3.44-11.67) | <0.001 | 3.17 (1.66-6.07) | <0.001 | Pathological N factor | | | | | N0 | Ref | | Ref | | N1 | 2.24 (1.67-3.00) | <0.001 | 1.80 (1.30-2.49) | <0.001 | N2 | 3.78 (2.34-6.10) | <0.001 | 2.26 (1.27-4.00) | 0.005 | N3 | 5.73 (4.10-8.01) | <0.001 | 3.63 (2.32-5.68) | <0.001 | Pathological stage | | | | | I | Ref | | | | II | 2.43 (1.41-4.18) | 0.001 | | | III | 6.82 (3.95-11.77) | <0.001 | | | IV | 6.61 (3.71-11.76) | <0.001 | | | Number of dissected LNs | 1.01 (0.99-1.02) | 0.37 | | | Number of positive LNs | 1.13 (1.10-1.17) | <0.001 | | | Rate of positive LNs | | | | | Postoperative complications | 10.06 (6.34-15.97) | <0.001 | 2.01 (0.91-4.43) | 0.008 | Postoperative pulmonary complications | 1.20 (0.92-1.55) | 0.18 | | | Postoperative anastomotic leakage | 1.59 (0.97-2.60) | 0.07 | | | Postoperative cardiovascular disease | 1.10 (0.82-1.46) | 0.54 | | | Sepsis | 1.82 (1.18-2.82) | 0.007 | 2.04 (1.31-3.18) | 0.002 |
|
|
BMI: body mass index; COPD: chronic obstructive pulmonary disease; NLR: neutrophil to lymphocyte ratio.
|